The lawsuit, brought on Kaine's behalf by his mother, Elizabeth Whitfield, alleged that the companies failed to warn that ...

In closing arguments on Wednesday, plaintiff's lawyer Timothy Cronin asked jurors for $6 billion in punitive damages.

"We are pleased with the jury’s decision," Abbott said in a statement emailed to Seeking Alpha. "The decision reinforces what ...

Abbott Laboratories and a unit of Reckitt Benckiser Group Plc were cleared by a jury over claims they hid risks their ...

In May 2023, the key player in the industry Otsuka Holdings Inc., launched the new liquid enteral nutrition product under the ...

MBA And Business Masters News, advice and resources from BusinessBecause - The authority on graduate management education for business school candidates worldwide ...

If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing ...

Abbott Labs delivered solid third-quarter results that featured strength across most of the cardiac device portfolio, ongoing US recovery in pediatric nutrition, and double-digit Libre growth.

Abbott (NYSE: ABT) recently reported its Q3 results, with revenues and earnings slightly above our expectations.

Abbott Laboratories, a healthcare giant with diverse divisions, is normalizing post-pandemic as its medical devices drive ...

In 2003, Abbott acquired JOMED's coronary and peripheral intervention business lines, and entered the healthy-living nutrition category with ZonePerfect Nutritional Co. "Throughout the 2000s ...